Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API

1 NDC API

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1392136-43-4, Verdinexor (kpt-335), Kpt-335, 85q03215iw, (z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)acrylohydrazide, (2z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)prop-2-enehydrazide

Molecular Formula

C₁₈H₁₂F₆N₆O

Molecular Weight

442.3 g/mol

InChI Key

OPAKEJZFFCECPN-XQRVVYSFSA-N

FDA UNII

85Q03215IW

Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).

1 2D Structure

Verdinexor

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyridin-2-ylprop-2-enehydrazide

2.1.2 InChI

InChI=1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4-

2.1.3 InChI Key

OPAKEJZFFCECPN-XQRVVYSFSA-N

2.1.4 Canonical SMILES

C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F

2.1.5 Isomeric SMILES

C1=CC=NC(=C1)NNC(=O)/C=C\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F

2.2 Other Identifiers

2.2.1 UNII

85Q03215IW

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (2z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)prop-2-enehydrazide

2. 2-propenoic Acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-, 2-(2-pyridinyl)hydrazide, (2z)-

3. Kpt-335

4. Kpt335

2.3.2 Depositor-Supplied Synonyms

1. 1392136-43-4

2. Verdinexor (kpt-335)

3. Kpt-335

4. 85q03215iw

5. (z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)acrylohydrazide

6. (2z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)prop-2-enehydrazide

7. 2-propenoic Acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-, 2-(2-pyridinyl)hydrazide, (2z)-

8. Kpt335

9. (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyridin-2-ylprop-2-enehydrazide

10. Verdinexor [usan:inn]

11. Unii-85q03215iw

12. Verdinexor [inn]

13. Kpt335;verdinexor

14. Verdinexor (usan/inn)

15. Verdinexor [usan]

16. Chembl3545187

17. Schembl14678337

18. Ex-a871

19. Kpt 335

20. Dtxsid301022535

21. Bcp11733

22. S7707

23. Zinc205957597

24. Ccg-269150

25. Db12207

26. Ncgc00386421-08

27. Ac-32682

28. Bs-15021

29. D11223

30. J-690155

31. Q27269660

32. 2-[(5-chloro-2-{[4-(1-piperazinyl)phenyl]amino}-4-pyrimidinyl)amino]-n-methylbenzamide

33. (z)-3-(3-(3,5-bis-(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)acrylohydrazide

34. 1656285-28-7

2.4 Create Date

2013-06-10

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₂F₆N₆O
Molecular Weight	442.3 g/mol
XLogP3	4.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	11
Rotatable Bond Count	5
Exact Mass	442.09767800 g/mol
Monoisotopic Mass	442.09767800 g/mol
Topological Polar Surface Area	84.7 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	620
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1